US Stock MarketDetailed Quotes
RUBY Rubius Therapeutics
- 0.057000
- 0.0000000.00%
15min DelayTrading Dec 29 16:00 ET
5.16MMarket Cap-28P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.057000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)90.48MShares0.05706052wk High0.34P/B2.25MFloat Cap-0.05474052wk Low--Dividend TTM39.52MShs Float38.652060Historical High--Div YieldTTM0.00%Amplitude-0.054740Historical Low--Avg Price1Lot Size
About Rubius Therapeutics Company
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.
Company Profile
SymbolRUBY
Company NameRubius Therapeutics
Issue Price23.00
CEOMs. Dannielle Appelhans
MarketPink Market
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.rubiustx.com
Company Executives
- Name
- Position
- Salary
- Dr. Pablo J. Cagnoni, M.D.
- Chairman of the Board
- 1.72M
- Dr. Catherine A. Sohn, Pharm.D.
- Independent Director
- 313.79K
- Sir Jonathan Richard Symonds CBE
- Independent Director
- 316.29K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg